Clinical Trials Logo

Stage IV Colorectal Cancer clinical trials

View clinical trials related to Stage IV Colorectal Cancer.

Filter by:

NCT ID: NCT01704703 Completed - Clinical trials for Stage IV Colorectal Cancer

Study of FOLFIRI + Panitumumab Using Ultra-selection Technology of Patients With Stage IV Colorectal Cancer Refractory to Irinotecan Without Any Mutation on KRAS, PIK3Ca, BRAF and NRAS Genes Detected With Highly Sensitive Techniques

ULTRA
Start date: October 2012
Phase: Phase 2
Study type: Interventional

Open label Phase II study of FOLFIRI + Panitumumab using ultra-selection technology with next generation high sensitivity genotyping of patients with stage IV colorectal cancer refractory to irinotecan without any mutation on KRAS, PIK3Ca, BRAF and NRAS genes detected with highly sensitive techniques.

NCT ID: NCT01550510 Terminated - Clinical trials for Stage IV Colorectal Cancer

Research Study of IV Vitamin C in Combination With Irinotecan vs Irinotecan Alone for Advanced Colorectal CA

Start date: December 2011
Phase: Phase 1/Phase 2
Study type: Interventional

This protocol is a phase I/II, study of ascorbic acid (AA) infusions combined with treatment with irinotecan versus treatment with irinotecan alone in patients with recurrent or advanced colorectal cancer who have failed at least one treatment regimen with a 5-FU based therapy. This study will be conducted as an amendment to Investigational New Drug # 77486.

NCT ID: NCT01271582 Active, not recruiting - Gastric Cancer Clinical Trials

Investigation of Association Between UGT1A1 Polymorphisms and Irinotecan Toxicity in Korean Patients

Start date: January 2009
Phase: Phase 4
Study type: Interventional

The purpose of this study is to investigate the association between UGT1A1 polymorphisms and neutropenia and diarrhea in Korean patients with advanced colorectal or gastric cancer treated with FOLFIRI regimen.

NCT ID: NCT01074385 Completed - Clinical trials for Stage IV Colorectal Cancer

Dignity Therapy in mCRC to Increase Peaceful Awareness & Impact Goals of Care Decision-Making

Start date: April 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to try and improve the way that patients with colon cancer understand and cope with their illness and give them tools for talking with their loved ones and family about their illness.

NCT ID: NCT00784446 Completed - Clinical trials for Stage IV Colorectal Cancer

First-line Therapy of Stage IV Colorectal Cancer

Start date: April 2008
Phase: Phase 1/Phase 2
Study type: Interventional

Assessment of safety and toxicity, definition of the dose limiting toxicity (DLT) of the combination therapy consisting of Capecitabine, Oxaliplatin, Bevacizumab and Imatinib.